Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort

Fig. 3

Drug retention rate of b/tsDMARDs. A, B Kaplan–Meier survival curves showing drug retention comparing different MOAs. The X-axis shows the number of days after b/tsDMARDs initiation, and the Y-axis shows the retention probability. Statistics used: log-rank test. A Drug retention in b/tsDMARD-naïve patients. B Drug retention in switched patients

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us